The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.
iShares Paris-Aligned ClmMSCIWldExUSAETF PABD
Morningstar’s Analysis PABD
Will PABD outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.49 | 1.4 Mil | Healthcare |
ASML Holding NV | 2.15 | 1.2 Mil | Technology |
Schneider Electric SE | 1.68 | 920,655 | Industrials |
Tokyo Electron Ltd | 1.43 | 782,818 | Technology |
ABB Ltd | 1.32 | 723,525 | Industrials |
AstraZeneca PLC | 1.31 | 717,302 | Healthcare |
Lvmh Moet Hennessy Louis Vuitton SE | 1.26 | 687,719 | Consumer Cyclical |
Novartis AG Registered Shares | 1.21 | 660,658 | Healthcare |
SAP SE | 1.17 | 637,221 | Technology |
Roche Holding AG | 1.04 | 570,817 | Healthcare |